Botulinum toxin type A injections have become a recognized treatment option for excessive sweating, known medically as hyperhidrosis. For individuals who.
Last reviewed: 2026-05-06
10 min read
Ready to explore your options in Istanbul?
Connect with our coordination team for a personalised treatment plan, verified provider matching, and travel logistics support.
Content is educational and planning-oriented. It does not replace diagnosis, treatment, or personalized medical advice from a licensed healthcare professional. Outcomes vary by individual case.
This content is general education and does not replace evaluation by a licensed clinician. If you have symptoms, complications, or urgent concerns, seek in-person medical care.
Key takeaways
Botox for hyperhidrosis is FDA-approved since 2004 for severe underarm sweating, with clinical trials showing 82-87% sweat reduction in many patients.
Providers should have specific training in hyperhidrosis injection protocols and intradermal techniques, which differs from cosmetic Botox training.
Standard treatment uses approximately 50 units per axilla in a grid pattern, but dosing varies by brand and individual patient factors.
Results typically last 4-12 months, with effects appearing within 2-4 days and full results at approximately 2 weeks for most patients.
International patients should verify provider credentials and understand follow-up care logistics before traveling for treatment.
Understanding Botox for Hyperhidrosis Treatment
Botulinum toxin type A injections have become a recognized treatment option for excessive sweating, known medically as hyperhidrosis. For individuals who have not found adequate relief from conventional antiperspirants, Botox offers a clinically studied alternative that can significantly reduce sweat production in targeted areas.
This resource is part of our broader Injectables & Botox Hub, which covers botulinum toxin treatments across various applications.
Clinical Evidence and Regulatory Approvals
The U.S. Food and Drug Administration approved onabotulinumtoxinA (Botox) in 2004 specifically for treating severe primary axillary hyperhidrosis in patients who do not obtain adequate relief using antiperspirants [S1]. This approval was based on clinical trial data demonstrating both safety and efficacy.
The treatment is approved in multiple countries globally for underarm excessive sweating. There are five FDA-approved botulinum toxin preparations available: Botox, Daxxify, Dysport, Myobloc, and Xeomin [S6]. Each product has specific dosing protocols, and unit doses are not interchangeable between brands—a critical consideration for provider qualification.
Clinical research published in peer-reviewed journals demonstrates that Botox treatment can reduce underarm sweating by 82-87% in many patients [S2]. This reduction makes it one of the more effective treatments available for moderate to severe hyperhidrosis that does not respond to topical therapies.
How Botox Works for Excessive Sweating
Botulinum toxin works by blocking the nerve signals that stimulate eccrine sweat glands. When injected intradermally (into the skin), the toxin temporarily prevents the release of acetylcholine, which is the chemical messenger that tells sweat glands to produce sweat [S4].
The treatment does not affect the body's ability to regulate temperature or eliminate toxins through other means—the body simply produces less sweat in the treated areas. This makes it particularly suitable for focal hyperhidrosis affecting specific areas like the underarms, palms, or feet.
The Hyperhidrosis Disease Severity Scale (HDSS) is a validated assessment tool clinicians use to evaluate treatment eligibility and measure outcomes. A score of 3 or 4 (on a 1-4 scale) typically indicates severe hyperhidrosis that may qualify for Botox treatment [S5].
Standard Treatment Protocols
Understanding clinical protocols helps you evaluate whether a provider follows evidence-based standards. This is particularly important when seeking treatment internationally.
The Minor Starch-Iodine Test: Mapping Treatment Areas
Before injection, providers typically perform the Minor starch-iodine test to map the exact areas of excessive sweating [S2]. This diagnostic procedure involves:
Applying iodine solution to the treatment area
Sprinkling starch powder over the iodine
Identifying areas where sweating causes a dark blue-black reaction
Marking these zones for targeted injection
This mapping ensures the treatment is delivered precisely where it's needed most, optimizing efficacy while minimizing the amount of product required.
Injection Techniques and Dosing Standards
The Botox Treatment Overview provides additional context on botulinum toxin applications beyond hyperhidrosis. The standard protocol for axillary (underarm) hyperhidrosis involves [S3]:
Dosing: Approximately 50 units of onabotulinumtoxinA per axilla
Injection pattern: Grid pattern with injections spaced 1-2 cm apart
Injection depth: Intradermal (into the skin, not muscle)
Number of sites: Typically 15-25 injection points per underarm
Brand-Specific Dosing
Brand-specific dosing is critical. Unit conversions differ significantly between products: Botox to Xeomin is approximately 1:1, while Botox to Dysport is roughly 1:2 to 1:3 [S6]. A provider unfamiliar with these conversions may administer incorrect doses, which could affect efficacy or increase the risk of side effects.
Palmar (hand) and plantar (foot) treatments follow similar protocols but often require modified dosing due to the sensitivity of these areas. Palmar injections may cause temporary hand weakness in some patients, which is an important consideration when planning treatment timing [S2].
Treatment Duration and Expected Results
Results typically appear within 2-4 days after treatment, with full effects visible at approximately 2 weeks [S2]. The duration of dryness varies significantly between individuals:
Average duration: 4-12 months
Some studies report: Up to 14 months in select patients
Palmar treatment: Often requires re-treatment at shorter intervals
Individual response varies based on factors including metabolism, injection technique, and the severity of hyperhidrosis. Patients should plan for periodic re-treatment to maintain results and discuss expectations with their provider.
Provider Accreditation and Training Standards
When selecting a provider—particularly when traveling internationally—verifying qualifications and training becomes important for safety and outcomes. Our Medical Team pages provide information about qualified practitioners and their credentials.
Who Should Administer Hyperhidrosis Botox
The International Hyperhidrosis Society recommends that hyperhidrosis Botox treatments be administered by [S3]:
Physicians with appropriate licensure in their jurisdiction
Nurse practitioners (NPs) or physician assistants (PAs) with appropriate supervision
Registered nurses (RNs) performing injections under physician oversight
Beyond basic medical licensure, practitioners should have specialized training in hyperhidrosis treatment and experience with intradermal injection techniques specific to sweat glands. This is not the same as cosmetic Botox training—the injection depth, pattern, and dosing differ substantially.
When researching providers, look for those who explicitly mention hyperhidrosis or excessive sweating as a treatment specialty, not just general cosmetic Botox services.
Training and Certification Pathways
The International Hyperhidrosis Society offers dedicated clinician education programs that establish recognized standards for hyperhidrosis treatment [S3]. Providers who have completed specialized training demonstrate competency in:
Proper patient assessment and HDSS scoring
Minor starch-iodine test execution
Product-specific dosing protocols
Intradermal injection techniques
Management of potential complications
State and national licensing requirements vary by jurisdiction. Before treatment, confirm that your provider holds current, active medical licensure and has documented training in hyperhidrosis specifically.
Questions to Ask Your Provider
When evaluating a provider, consider asking:
How many hyperhidrosis Botox treatments do you perform monthly?
What training have you completed specifically for hyperhidrosis?
Which botulinum toxin products do you use, and why?
Do you perform the Minor test to map treatment areas?
What is your protocol if I experience excessive weakness or other complications?
What happens if I need touch-up treatment after returning home?
Red Flags
Watch for: providers who refuse to disclose credentials, cannot describe the Minor test, guarantee specific results, or use pressure tactics to book immediately without proper evaluation.
Safety Protocols and Risk Management
Understanding the safety profile helps you recognize what constitutes appropriate care and when to seek medical attention. Our Facility Standards outline the accreditation and safety protocols maintained by our partner facilities.
Treatment Safety Profile
Botox for hyperhidrosis has an established safety profile when administered by qualified professionals. Clinical data and real-world use indicate that adverse events are typically mild and temporary [S2]:
Common side effects (affecting a significant minority of patients):
Injection-site pain or discomfort
Bruising at injection sites
Mild swelling or redness
Less common effects:
Temporary hand weakness (more likely with palmar treatment)
Temporary facial asymmetry (if treated for craniofacial sweating)
Headache
Rare complications:
Botulinum toxin resistance develops in approximately 1-3% of patients [S2]
This resistance may result from antibody formation with repeated treatments
Compensatory sweating—where other body areas increase sweating after treatment—has been reported following surgical sympathectomy but has not been found to be a significant concern with Botox injections [S2].
Managing Potential Side Effects
Most side effects are self-limiting and resolve without intervention. However, certain symptoms warrant prompt medical attention:
Severe or worsening weakness in treated limbs
Difficulty swallowing, speaking, or breathing (signs that require immediate medical evaluation)
Signs of infection at injection sites
Any unexpected symptoms that concern you
Before treatment, disclose all medical conditions, medications, and previous Botox treatments to your provider. Certain neurological conditions, pregnancy, and breastfeeding may affect treatment suitability [S4]. Consult with your healthcare provider to determine whether this treatment is appropriate for your specific situation.
What to Expect: Treatment Planning
Expected Results and Duration
Based on clinical data, patients can expect [S2][S4]:
Initial response: 2-4 days post-treatment
Full results: Approximately 2 weeks
Sweat reduction: 82-87% in many patients
Duration: Generally 4-12 months before re-treatment is needed
The Hyperhidrosis Disease Severity Scale provides a standardized way to measure improvement. Many patients move from severe (HDSS 3-4) to mild (HDSS 1-2) after successful treatment [S5].
Preparing for Your Appointment
To prepare for treatment:
Avoid blood thinners: Refrain from aspirin, ibuprofen, or similar medications for 1-2 weeks before treatment if medically safe
Shave underarms: If applicable, shave axillary hair 1-2 days before treatment
Wear comfortable clothing: Loose sleeves make injection access easier
Bring medical records: Previous treatment records can inform current care
Plan travel timing: Results develop over 1-2 weeks, so factor this into travel plans
Follow-Up Considerations for International Patients
Traveling for treatment requires additional planning for follow-up care. Our International Patient Services can help coordinate logistics, including accommodation, transportation, and follow-up care coordination.
Request written documentation of your treatment (product used, dose, injection sites, date)
Ask about provider availability for remote consultation if needed
Understand that touch-up treatments may be needed and plan accordingly
Consider having a local provider for any urgent concerns
Action Checklist
Use this checklist when evaluating providers and planning your treatment:
[ ] Verify provider has specific training in hyperhidrosis Botox treatment
[ ] Confirm the provider uses the Minor starch-iodine test for mapping
[ ] Ask which botulinum toxin product is used and confirm brand-specific dosing
[ ] Request information about typical duration and re-treatment expectations
[ ] Discuss what happens if you experience complications
[ ] Understand the complete cost, including any potential follow-up treatments
[ ] Plan travel timing to allow 2 weeks for full results before returning home if needed
[ ] Get written documentation of your treatment to share with any future providers
Medical Travel Tip
When traveling internationally for hyperhidrosis treatment, consider combining your procedure with other planned activities, but allow adequate time for initial recovery and to recognize any unexpected reactions before long-distance travel.
Understanding the clinical protocols, provider qualifications, and safety considerations empowers you to make informed decisions about hyperhidrosis Botox treatment. Whether you receive treatment locally or internationally, the same evidence-based standards should apply.
For patients considering treatment in Istanbul, verifying that providers follow these established protocols—specialized training, proper mapping techniques, brand-specific dosing, and appropriate follow-up care—helps ensure safety and optimal outcomes.
